PITTSBURGH, Aug. 22, 2014 /PRNewswire/ -- Mylan Inc. (MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the ...